Capecitabine-related neurotoxicity presenting as trismus

Clinical Colorectal Cancer

Volumn 3, Issue 2, 2003, Pages 121-123

  Couch, Linda S B ^a   Groteluschen, David L ^a   Stewart, James A ^a   Mulkerin, Daniel L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Acute cerebellar syndrome; Adverse drug reaction; Bulbar palsy; Colorectal cancer; Neurotoxicity

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CAPECITABINE; DILTIAZEM; ESTRADIOL; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; FUROSEMIDE; IRINOTECAN; OXYCODONE; WARFARIN;

ACUTE DISEASE; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPNEA; ELECTROENCEPHALOGRAPHY; EYE DISEASE; FEMALE; GAIT DISORDER; HEART ATRIUM FIBRILLATION; HUMAN; LYMPHADENOPATHY; METASTASIS; NEUROMUSCULAR DISEASE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS ABSCESS; RECTUM CANCER; SLURRED SPEECH; TACHYCARDIA; TACHYPNEA; TRISMUS; VEIN THROMBOSIS;

EID: 0041380987     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2003.n.019     Document Type: Article

References (19)

1. Heidelberger C, Chaudhuari N, Dannenberg P, et al. Fluorinated pyrimidines, a new class of tumor inhibiting compounds. Nature 1957; 179:633-666.
2. Lokich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program study. J Clin Oncol 1989; 7:425-432.
3. Takebayashi Y, Akiyama S, Akiba S, et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996; 88:1110-1117.
4. Ishikawa T, Sekiguchi F, Fukase Y, et al. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res 1998; 58:685-690.
5. Schuller J, Cassidy J, Dumont E, et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 2000; 45:291-297.
6. De Vita VT Jr, Hellman SH, Rosenberg SA, eds. Cancer Principles & Practice of Oncology, 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001.
7. Van Cutsem E, Findlay M, Osterwalder B, et al. Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol 2000; 18:1337-1345.
8. Recht LD, Primavera JM. Neurologic disorder in a 65-year-old man after treatment of colon cancer. N Engl J Med 1999; 341:512-519.
9. Weiss HD, Walker MD, Wiernik PH. Neurotoxicity of commonly used antineoplastic agents. N Engl J Med 1974; 291:75-81.
10. Riehl JL, Brown WJ. Acute cerebellar syndrome secondary to 5-fluorouracil therapy. Neurology 1964:961-967.
11. Budman DR, Meropol NJ, Reigner B, et al. Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine. J Clin Oncol 1998; 16:1795-1802.
12. Aoki N. Reversible leukoencephalopathy caused by 5-fluorouracil derivatives presenting as akinetic mutism. Surg Neurol 1986; 25:279-282.
13. Pirzada N, Ali I, Dafer R. Fluorouracil-induced neurotoxicity. Ann Pharmacother 2000; 34:35-38.
14. Bofill JS, Chaves M, Moreno JA. Fluorouracil-induced aphasia. Ann Pharmacother 2000; 34:955.
15. Takimoto CH, Lu ZH, Zhang R, et al. Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. Clin Cancer Res 1996; 2:477-481.
16. Berry FA, Lynch C. Succinylcholine and trismus. Anesthesiology 1989; 70:161-163.
17. Cope MR. Metoclopramide-induced masticatory muscle spasm. Br Dent J 1983; 154:335-336.
18. Yeh KH, Cheng AL. High dose 5-fluorouracil therapy is associated with hyperammonemia, lactic acidosis and encephalopathy. Br J Cancer 1997; 75:464-465.
19. Sloan JA, Goldberg RM, Sargent DJ, et al. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol 2002; 20:1491-1498.